Cited by 982Asthma and respiratory diseasesChronic Obstructive Pulmonary Disease (COPD) ResearchIL-33, ST2, and ILC Pathways

The cytokine network in asthma and chronic obstructive pulmonary disease

Open access
Barnes, Peter J.·2008·Journal of Clinical Investigation

Abstract

Asthma and chronic obstructive pulmonary disease (COPD) are very common inflammatory diseases of the airways. They both cause airway narrowing and are increasing in incidence throughout the world, imposing enormous burdens on health care. Cytokines play a key role in orchestrating the chronic inflammation and structural changes of the respiratory tract in both asthma and COPD and have become important targets for the development of new therapeutic strategies in these diseases.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci36130

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

No citation lists for this paper

No citation lists for this paper yet — checked again daily.

References 130 · Cited by 982

Research works printed but not linked: 7

  1. Dentener, M.A., et al. 2008. Effect of infliximab on local and systemic inflammation in chronic obstructive pulmonary disease: a pilot study. Respiration. 76:275-282. doi:10.1159/000117386. · DOI
  2. Erin, E.M., et al. 2008. Rapid anti-inflammatory effect of inhaled ciclesonide in asthma: a randomised, placebo-controlled study. Chest. Online publication ahead of print. doi:10.1378/chest.07-2575. · DOI
  3. Gajewska, B.U., Wiley, R.E., and Jordana, M. 2003. GM-CSF and dendritic cells in allergic airway inflammation: basic mechanisms and prospects for therapeutic intervention. Curr. Drug Targets Inflamm. Allergy. 2:279-292.
  4. Nassenstein, C., Kutschker, J., Tumes, D., and Braun, A. 2006. Neuro-immune interaction in allergic asthma: role of neurotrophins. Biochem. Soc. Trans. 34:591-593.
  5. Wan, Y.Y., and Flavell, R.A. 2007. Regulatory T cells, transforming growth factor-beta, and immune sup- pression. Proc. Am. Thorac. Soc. 4:271-276.
  6. Ning, W., et al. 2004. Comprehensive gene expres- sion profiles reveal pathways related to the patho- genesis of chronic obstructive pulmonary disease. Proc. Natl. Acad. Sci. U. S. A. 101:14895-14900.
  7. Sharpless, A.P. 2007 September 25. Pharmacopeia earns milestone payment from Schering-Plough on initiation of Phase 1 clinical trials of novel thera- peutic candidate [press release]. Princeton, New Jersey, USA. http://www.pharmacopeia.com/wt/ page/press/pr_1190725994.

Authors
Barnes, P. J.
Affiliations
Imperial College London (GB)
Corresponding author
Barnes, Peter J.
Venue
Journal of Clinical Investigation
Published
2008-11-03
Volume
118
Issue
11
Pages
3546-3556
ISSN
0021-9738 (ISSN-L)
OpenAlex
W2050237494
Cited by
982
References
130
Citations by year
2026: 30 · 2025: 43 · 2024: 25 · 2023: 28 · 2022: 55 · 2021: 59 · 2020: 67 · 2019: 55 · 2018: 54 · 2017: 66 · 2016: 88 · 2015: 63 · 2014: 56 · 2013: 73 · 2012: 71
FWCI
5.39
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Investigation (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • AstraZeneca
  • GlaxoSmithKline
  • Daiichi-Sankyo
Topics
  • Health Sciences › Medicine › Physiology › Asthma and respiratory diseases
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
  • Life Sciences › Immunology and Microbiology › Immunology › IL-33, ST2, and ILC Pathways
Keywords
cytokines, asthma, chronic obstructive pulmonary disease, airway inflammation, airway remodeling, chronic inflammation, therapeutic target
MeSH terms
Asthma, Humans, Models, Biological, Cytokines, Pulmonary Disease, Chronic Obstructive

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review